Work

The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.127

Authors: Luke Meininger, Ravi Amrit Madan, Nicole Toney, Renee Nicole Donahue, Margaret Elena Gatti-Mays, Julius Strauss, Fatima Karzai, Marijo Bilusic, Jennifer L. Marte, Lisa M. Cordes, Jason Redman, Charalampos S. Floudas, Danielle M. Pastor, William Douglas Figg, William L. Dahut, Jeffrey Schlom, James L. Gulley

Institutions: Walter Reed National Military Medical Center, National Institutes of Health, National Cancer Institute, University of Miami, Sylvester Comprehensive Cancer Center, Center for Cancer Research

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4212814962

Cites:

Cited by: 4

Related to: 10